Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.
about
Breast cancer intrinsic subtype classification, clinical use and future trendsA 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.Molecular stratification of early breast cancer identifies drug targets to drive stratified medicineDissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomesThe CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer.The molecular pathology of breast cancer progression.Multigene prognostic tests in breast cancer: past, present, futureKLF6-SV1 drives breast cancer metastasis and is associated with poor survivalTumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Molecular tests as prognostic factors in breast cancer.Multi-gene classifiers for prediction of recurrence in breast cancer patients.Gene expression-based prognostic and predictive tools in breast cancer.Gene-Expression-Based Predictors for Breast Cancer.Biomarker assessment and molecular testing for prognostication in breast cancer.Gene expression profiling in breast cancer.Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens.Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories.Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.The Genomic Grade Index predicts post-operative clinical outcome in patients with soft tissue sarcoma.Genes and functions from breast cancer signatures.18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.Endocrine Resistance in Breast Cancer
P2860
Q26773761-C1CD352E-4CD0-41B9-AA74-FB5BC3060DBFQ30421675-53032B94-0295-4C8A-ACBA-F0F95285B765Q33731350-0116AF14-E03C-4A36-875B-A18B07DA2B2FQ33897072-0DF20D09-C1AC-4A16-BA7A-6C5763E3D0FAQ34374191-E19ACD63-FF98-4BA3-B6A6-B95F2E97D9DEQ34611524-9D73401F-52E6-4DE4-9CCE-E7102988B164Q34752938-5AE68B3B-BFBA-4595-BF35-E43F0FC2371AQ35018599-83CCF43F-FD36-480D-9E1B-6A36E91A9F1CQ36324431-7C5EA99B-C323-4207-B038-3266C21BEC5EQ37072929-F8AC35F1-A995-4665-9F84-19581794B596Q37383276-6AABB422-FAC4-44B7-BCEA-E1455111DF1AQ38184381-4C249780-19D2-4D1E-9A66-D6022C0BBFE3Q38362985-7EBE6F2E-517F-4E0E-8061-39A02BFF3EBBQ38421414-B7B70AC6-2B94-4647-BB2D-16A6C52B2C10Q38555220-1396BE29-7E9E-4522-84FE-2B7E5A5F53D2Q38696790-134FE363-CB26-4DC8-BA70-D3420D3FCC5EQ39449343-E0938292-C600-47E0-A890-5B3BD31E5806Q39679700-EB32FEAE-AD89-4FE6-8E4A-3CBB234AACDCQ41260173-CCDC2562-3D5F-4266-96D2-2FDDE896030BQ41737188-ED1849E7-5E04-4CA6-B736-31BD14C6E301Q43627028-38266676-FE71-4D35-9F7E-F46F120616C0Q46083625-ADE3FC6C-BC46-479C-B6EC-9AC750419508Q47720588-AD6912D2-A308-4D6B-859B-E6D76F702053Q52560707-C9B6FFCC-716B-4BC6-B085-0B88C79C502FQ52584340-326E4931-E50E-4812-BB36-7FDBF173F94CQ52886164-C5514510-28CF-4C2A-96C3-167ADFAF290FQ55438434-D92FC54A-FDFE-4107-8C15-31A9D31C9BD0Q59072640-ED32EECD-93AF-40F7-B66E-C4585E44C1C4
P2860
Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@ast
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@en
type
label
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@ast
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@en
prefLabel
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@ast
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@en
P2093
P2860
P50
P356
P1433
P1476
Improvement of the clinical ap ...... xed paraffin-embedded tissues.
@en
P2093
Anieta M Sieuwerts
Christos Sotiriou
Denis Larsimont
Ghizlane Rouas
John A Foekens
Jérôme Toussaint
Martine Piccart
Virginie Durbecq
P2860
P2888
P356
10.1186/1471-2164-10-424
P407
P577
2009-09-10T00:00:00Z
P5875
P6179
1045581956